dasatinib sandoz 50 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 50 mg - urbroj: svaka filmom obložena tableta sadrži 50 mg dasatiniba
dasatinib sandoz 100 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 100 mg - urbroj: svaka filmom obložena tableta sadrži 100 mg dasatiniba
dasatinib sandoz 140 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 140 mg - urbroj: svaka filmom obložena tableta sadrži 140 mg dasatiniba
dasatinib sandoz 20 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 20 mg - urbroj: svaka filmom obložena tableta sadrži 20 mg dasatiniba
dasatinib sandoz 70 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 70 mg - urbroj: svaka filmom obložena tableta sadrži 70 mg dasatiniba
dasatinib sandoz 80 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 80 mg - urbroj: svaka filmom obložena tableta sadrži 80 mg dasatiniba
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib teva 100 mg filmom obložene tablete
teva b.v., swensweg 5, haarlem, nizozemska - dasatinib hidrat - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba (u obliku hidrata)
dasatinib teva 20 mg filmom obložene tablete
teva b.v., swensweg 5, haarlem, nizozemska - dasatinib hidrat - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba (u obliku hidrata)